Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
Bruce I Gaynes1,2, Anne Onyekwuluje11Departments of Ophthalmology and 2Pharmacology, Rush College of Medicine, Chicago, Illinois, USAAbstract: The removal of diclofenac sodium ophthalmic solution as a viable pharmaceutical entity in September 1999 from the US market spurred considerable interest in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-06-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | http://www.dovepress.com/topical-ophthalmic-nsaids-a-discussion-with-focus-on-nepafenac-ophthal-a1791 |